AUS
NZ
UK
CA
USA
IND
Healthcare
Looking Through The Business Model Of This Drug Development Company – Noxopharm
May 10, 2019 12:06 PM AEST| By Team Kalkine MediaNoxopharm Limited (ASX: NOX) rides on its overarching objective for a treatment ?to harness the body?s immune system to attack all the cancer cells in the body, but with noticeably reduced side-effects. The company is positioned as a clinical-stage d...
AirXpanders, Inc. Appoints Cowen Inc. As Financial Advisor
May 09, 2019 10:21 PM AEST| By Team Kalkine MediaAirXpanders, Inc. (ASX: AXP) is a healthcare company engaged in the development of the AeroForm? Tissue Expander System. The company provides design, manufacturing, sale and distribution for the device. In an announcement made on 9 May 2019, the com...
Zelda Receives Cash Refund Of $769,000 Under R&D Tax Incentive Scheme
May 09, 2019 07:12 PM AEST| By Team Kalkine MediaHeadquartered in Australia, Zelda Therapeutics Limited (ASX: ZLD) develops cannabinoid-based medicines to treat human diseases and disorders. The company is uniting with the world?s leading researchers and clinicians undertaking the study and use of...
CLINUVEL Pharmaceuticals’ Shares Zoomed Up On ASX; All That Investors Need To Know
May 09, 2019 04:46 PM AEST| By Team Kalkine MediaCLINUVEL Pharmaceuticals Limited (ASX: CUV), based in Melbourne, is a global biopharmaceutical company dedicated to developing and providing treatments for the patients suffering from severe genetic or UV-rays related skin disorders worldwide. CLINU...
MMJ Group Reveals Business Update To Investors
May 09, 2019 12:23 PM AEST| By Team Kalkine MediaHeadquartered in Australia, MMJ Group Holdings Ltd (ASX: MMJ) works with cannabis-related companies like Harvest One, Martha Jane Medical and MediPharm Labs. The company aims to invest across the full range of cannabis-related sectors. The company r...
Orthocell Stock Up 356% On The Clinical Response Of CelGro®
May 08, 2019 08:44 PM AEST| By Team Kalkine MediaOrthocell Limited (ASX: OCC) is a pharmaceutical company based in Australia. The company specialises in regenerative medicine, regeneration of tissue and restoring mobility, offering new techniques to the regeneration of tendon, repair, soft tissue i...
Paradigm Reports Significant Reductions In BML In Various Body Sites
May 08, 2019 05:12 PM AEST| By Team Kalkine MediaParadigm Biopharmaceuticals Ltd (ASX: PAR) is an ASX listed healthcare company, focusing on repurposing pentosan polysulphate sodium (PPS) for the treatment of medical conditions that have an active role in inflammation. The important properties of t...
HeraMed partners with Turkey-based Medizane; broadens European Distribution network
May 08, 2019 04:06 PM AEST| By Team Kalkine MediaHeraMed Limited (ASX: HMD), established in 2011 and based out of West Perth, is a medical technology company that develops and sells pregnancy monitoring solutions for home and professional use for patients in Europe, Israel and Australia. Currently,...
MGC Pharma Receives First Shipment Of CannEpil™ In The UK; Stock Up 16%!
May 07, 2019 08:49 PM AEST| By Team Kalkine MediaMGC Pharmaceuticals Ltd (ASX: MXC), a leading cannabinoid bio-pharma company, is involved in delivering high-quality cannabinoids based pharmaceuticals products to markets of Australasia, Europe and North America. The company announced today that th...
MedAdvisor Sets Up ZPM, A New JV With Zuellig Pharma
May 07, 2019 08:04 PM AEST| By Team Kalkine MediaMedAdvisor Limited (ASX: MDR) is a health care company based in Camberwell, Australia. The company provides a medication management platform to aid people in making the best use of medicines. The company?s mobile and web apps are easy to use and simp...
CannPal Announces Phase 1 Results For Its Lead Drug Candidate CPAT-01
May 07, 2019 07:50 PM AEST| By Team Kalkine MediaCannPal Animal Therapeutics Limited (ASX: CP1), a pharmaceutical company focused on products for veterinary therapeutics derived from cannabis. CannPal is developing and researching therapeutics for veterinarians derived from cannabinoids for the tre...
Actinogen Medical Released Alzheimer’s Disease Trial
May 07, 2019 02:51 PM AEST| By Team Kalkine MediaBiotechnology company Actinogen Medical Limited?s (ASX: ACW) lead compound Xanamem has failed to demonstrate adequate efficacy in improving cognition in mild Alzheimer?s disease. In an update provided on 7 May 2019, the company announced the results...
PharmAust Receives Positive Results from Ongoing Phase I Trial Program
May 07, 2019 12:29 PM AEST| By Team Kalkine MediaPharmAust Limited (ASX: PAA) is a clinical-stage company, developing targeted cancer therapeutics to address both humans as well as animal healthcare. On 7th February 2019, PharmAust Limited entered into an agreement with US Contract Research Organi...
KZA Announces Superior Safety and Tolerability Data From GDC-0084’s Phase IIa Study
May 06, 2019 09:36 PM AEST| By Team Kalkine MediaKazia Therapeutics Limited (ASX: KZA) is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. On 6th May 2019, Kazia Therapeutics Limited announced new safety data from its ongoing Phase IIa study of GDC-0084 in the new...
MGC Pharma Announces Partnership with Grow Biotech and IPS
May 06, 2019 03:26 PM AEST| By Team Kalkine MediaAn EU-based BioPharma company, MGC Pharmaceuticals Ltd (ASX: MXC) is an expert in the medical cannabis industry. The company?s strategy is to deliver high-quality cannabinoids-based pharmaceuticals products in the European, North American and Austral...
A Look At Healthcare Stock - VHT
May 05, 2019 08:00 AM AEST| By Team Kalkine MediaVolpara Health Technologies Limited (ASX: VHT) is a health sector company of New Zealand and a leading provider of breast imaging analytics and analysis products that deliver personalised breast cancer screening software applications. The AI imaging...
How Are Investor’s Eyeing These Healthcare Stocks – CSL, RMD, COH, NAN
May 04, 2019 08:00 AM AEST| By Team Kalkine MediaCSL Limited (ASX: CSL) CSL Limited (ASX: CSL) is engaged in the business of biopharmaceutical and allied products with R&D, manufacturing, marketing and distribution. Basically, the group operates through two segments ? (1) CSL Behring: focuses...
Noxopharm Advances One-Step up on Its Cancer Management Program
May 03, 2019 07:00 PM AEST| By Team Kalkine MediaUnearthing the long-lasting responses with Veyonda? in the treatment of prostate cancer Clinical-stage drug development company, Noxopharm Limited (ASX: NOX) lately announced the 6-month interim results from the dose-escalation arm of the DARRT-1 st...
Favourable for IPD: ASBrS Releases PREVENT Abstract; BIS Found Effective
May 03, 2019 04:42 PM AEST| By Team Kalkine MediaImpediMed Limited (ASX: IPD) is engaged in the business of production and designing of medical devices with BIS (Bioimpedance Spectroscopy) technologies to non-invasively measure, manage and monitor tissue composition and fluid status. The company to...
Respiri to Enter Indian Market; Announces JV with MedAchievers Private Limited
May 03, 2019 04:17 PM AEST| By Team Kalkine MediaToday, on 3rd May 2019, Respiri Limited (ASX: RSH) announces a Joint Venture Agreement for the company?s entry into India with MedAchievers Private Limited, which is an integrated platform for global healthcare, led by Dr Harsha Vardhan, Founder and...
Advertise your brand on Kalkine Media